Sri Krishna Mukkamala, MD
Hospitalist · Cumming, GANPI 1710184148
Payments from drug & device makers
Across 557 payments — averaging $435.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$182K
- Genentech USA, Inc.$22K
- Novartis$11K
- Alimera Sciences, Inc.$8K
- US Retina LLC$6K
- Notal Vision, Inc.$5K
- plus $9K from 22 others
What the payments were for
- Consulting fees$22,82410%
- Speaking & faculty fees$175,85473%
- Travel & lodging$22,0859%
- Food & beverage$13,3236%
- Ownership interest$5,7232%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 213 | $181,635 |
| Genentech USA, Inc. | 52 | $21,887 |
| Novartis | 21 | $11,261 |
| Alimera Sciences, Inc. | 45 | $8,462 |
| US Retina LLC | 12 | $5,723 |
| Notal Vision, Inc. | 88 | $5,000 |
| Nidek Incorporated | 1 | $3,492 |
| Astellas Pharma US Inc | 23 | $785 |
| AbbVie(2 entities) | 24 | $684 |
| Apellis Pharmaceuticals, Inc. | 18 | $585 |
| Eyepoint US, Inc. | 9 | $484 |
| ANI Pharmaceuticals, Inc. | 12 | $465 |
| Carl Zeiss Meditec USA, Inc. | 4 | $396 |
| Alcon | 5 | $332 |
| NEW World Medical,inc. | 1 | $210 |
| Bausch & Lomb Americas Inc. | 4 | $192 |
| Regeneron | 2 | $178 |
| Coherus Oncology, Inc. | 8 | $176 |
| Sight Sciences, Inc. | 1 | $147 |
| Mallinckrodt Hospital Products Inc. | 1 | $126 |
| Rxsight Inc | 1 | $125 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $123 |
| Biogen | 4 | $75 |
| Sandoz | 2 | $67 |
| Halozyme Inc | 2 | $52 |
| Teleflex LLC | 1 | $25 |
| Amgen | 1 | $19 |
| Mallinckrodt Enterprises LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EYLEA$118,677
- EYLEA HD$59,646
- VABYSMO$20,443
- Iluvien$7,723
- SUSVIMO$3,909
- Lucentis$2,520
- BEOVU$2,239
- YUTIQ$2,102
- DEXYCU$250
- Kahook Dual Blade$210
- Clearpath$210
- Ahmed Glaucoma Valve$210
- Streamline$210
- Via360$210
- OZURDEX$149
- OMNI(R) SURGICAL SYSTEM (US)$147
- XIPERE$145
- VISUDYNE$145
- Constellation$139
- Clarus 700$133
How this compares
$242,719 in reported general payments places this provider in the 95th percentile of 812 hospitalist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 105 | $4,909 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 14 | $3,037 |
| Brimonidine Tartrate | 38 | $2,895 |
| Atropine Sulfate | 60 | $2,040 |
| Latanoprost | 200 | $1,909 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 34 | $451 |
| Ciprofloxacin Hcl | 26 | $374 |
| Timolol Maleate | 33 | $344 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 52 | $315 |
| Dorzolamide Hcl | 11 | $291 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Cumming
- Vasundhara CheekatiLawrenceville$2.3M
- Neelima SurapaneniAtlanta$308K
- Sara DawitRoswell$190K
- Roohi FaiyazGainesville$174K
- Kamardeen AlabiHiram$87K
- Gul MughalDuluth$33K
- Annie ParkCanton$19K
- Philippa AmeneGainesville$11K
- Daryl McCartneyStatesboro$9K
- Anna SikodGainesville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.